Mercury Pharmachem Industries Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 41 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
- Revenue Growth 2.15%
- Profit Growth -36.26%
- Ebitda -6.26%
- Net Worth 287.61%
- Total Assets 10.78%
About Mercury Pharmachem Industries
Mercury Pharmachem Industries Pvt Ltd (MPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 May 1983 and has a history of 41 years and eight months. Its registered office is in Panvel, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 Cr.
Vinit Premchand and Akshat Shah serve as directors at the Company.
Company Details
-
Location
Panvel, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH1983PTC030037
-
Company No.
030037
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 May 1983
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mercury Pharmachem Industries?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinit Premchand
|
Director | 23-Jan-2023 | Current |
|
Akshat Shah
|
Director | 12-Sep-2022 | Current |
Financial Performance of Mercury Pharmachem Industries.
Mercury Pharmachem Industries Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 2.15% increase. The company also saw a substantial fall in profitability, with a 36.26% decrease in profit. The company's net worth Soared by an impressive increase of 287.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mercury Pharmachem Industries?
In 2023, Mercury Pharmachem Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vinipul Chemicals Private LimitedVinit Premchand and Akshat Shah are mutual person
Charges (Loans)
₹90.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 9.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2023 | Others | ₹9.00 Cr | Open |
How Many Employees Work at Mercury Pharmachem Industries?
Unlock and access historical data on people associated with Mercury Pharmachem Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mercury Pharmachem Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercury Pharmachem Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
